Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy-Reference-Cited by-同舟云学术

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy

Published:2023-03 Issue:2 Volume:8 Page:101143
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Laughlin Brady S.^ORCID,Voss Molly M.,Toesca Diego A.S.,Daniels Thomas,Golafshar Michael A.,Keole Sameer R.,Wong William W.,Rwigema Jean-Claude,Davis Brian,Schild Steven E.,Stish Brad J.,Choo Richard,Lester Scott,DeWees Todd A.,Vargas Carlos E.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference49 articles.

1. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95;Wiegel;J Clin Oncol,2009

2. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911);Bolla;Lancet,2012

3. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial;Thompson;J Urol,2009

4. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): A randomised, multicentre, open-label phase 3 trial;Carrie;Lancet Oncol,2016

5. Radiation with or without antiandrogen therapy in recurrent prostate cancer;Shipley;N Engl J Med,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASTRO’s Advances in Radiation Oncology’s Top Downloaded Articles of 2023;Advances in Radiation Oncology;2024-08

2. 10-yr Results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity;Clinical Genitourinary Cancer;2024-08

3. Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study;Clinical and Translational Radiation Oncology;2024-01

4. Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies;Frontiers in Oncology;2023-07-04

5. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance;Cancers;2022-12-21